CATALYST FINANCIAL PARTNERS LLC

Position in EW — Edwards Lifesciences Corp

CIK 1927537 BOSTON, MA

Position in EW

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$306,388

+$8,010 QoQ

Shares Held

3,387

-9.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#888

of 1,315 holders

Holding Since

Jun 2023

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $9,789,819 across 6 Medical Devices names. EW ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UFPT	Ufp Technologies Inc	26,457	$7,014,544
2	ABT	Abbott Laboratories	10,696	$970,555
3	SYK	Stryker Corp	1,904	$599,455
4	MDT	Medtronic plc	6,711	$525,001
5	BSX	Boston Scientific Corp	8,760	$373,876
6	EW	Edwards Lifesciences Corp This page	3,387	$306,388

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$306,388	3,387	-9.1%	Shares	Sole	2026-07-30
2026-03-31	$298,378	3,726	+40.3%	Shares	Sole	2026-05-12
2025-12-31	$226,424	2,656	+4.8%	Shares	Sole	2026-02-04
2024-06-30	$234,065	2,534	+10.1%	Shares	Sole	2024-07-25
2024-03-31	$219,979	2,302	+1.1%	Shares	Sole	2024-04-23
2023-06-30	$214,695	2,276	—	Shares	Sole	2023-08-02
No filing history on record for this holder in this stock.